Jump to Navigation

We have made an update to FoundationOneHeme.

Patient samples will no longer be qualified based on age, and solid tumor samples from pediatric patients will now be profiled by FoundationOne.

Learn More

Learn how comprehensive genomic profiling is impacting patient care today.

Stop by our booth #307 at USCAP, 2015 to experience our virtual lab tour.
View our posters and presentations schedule.

Introducing the latest version of Foundation Medicine’s
Interactive Cancer Explorer – ICE 2

Features a brand new approach to increasing the actionability of FoundationOne and FoundationOne Heme results: PatientMatch.

Learn More

Did you know

that more than 30% NSCLC patients with ALK fusions may have tested negatively for ALK by FISH*?

Learn more about the importance of comprehensive genomic profiling in lung cancer.

Every Cancer is Unique

Learn more about how FoundationOne can
help tailor your treatment options.

What is FoundationOne?

FoundationOne is a fully informative genomic profile that helps physicians make treatment decisions for patients with cancer by identifying the molecular growth drivers of their cancers and helping oncologists match them with relevant targeted therapeutic options.

Watch Now
Cancer and Treatment Options

Discover more about cancer and learn about available treatment options.

Watch Now
Featured Publications

View a list of our published and presented studies.

Read Now
Order a Test

Order Now

If you are a physician, there are a few ways to get started using FoundationOne (for solid tumors) or FoundationOne Heme (for hematologic malignancies and sarcomas) in your clinical practice.

If you are a patient, contact us for more information so you can talk with your doctor to see if FoundationOne or FoundationOne Heme is right for you.